These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7415875)

  • 1. Production and antigenic effect of experimental sheep adenovirus vaccines.
    Pálfi V; Belák S
    Acta Microbiol Acad Sci Hung; 1980; 27(2):135-9. PubMed ID: 7415875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response of mice and sheep to bluetongue virus inactivated by gamma irradiation.
    Campbell CH; Barber TL; Knudsen RC; Swaney LM
    Prog Clin Biol Res; 1985; 178():639-47. PubMed ID: 2989913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and preliminary testing of an inactivated equine adenovirus vaccine.
    Lew AM; Smith HV; Studdert MJ
    Am J Vet Res; 1979 Dec; 40(12):1707-12. PubMed ID: 525889
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral administration of an attenuated strain of canine adenovirus (type 2) to raccoons, foxes, skunk, and mongoose.
    Sumner JW; Shaddock JH; Wu GJ; Baer GM
    Am J Vet Res; 1988 Feb; 49(2):169-71. PubMed ID: 3348527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sheep-pox vaccine prepared from formaldehyde inactivated virus adsorbed to aluminium hydroxide gel.
    Sólyom F; Perenlei L; Roith J
    Acta Microbiol Acad Sci Hung; 1982; 29(2):69-75. PubMed ID: 6291337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro blastogenesis of equine lymphocytes by inactivated equine adenovirus type 1 antigen.
    Campbell TM; Studdert MJ
    Am J Vet Res; 1982 Nov; 43(11):1922-5. PubMed ID: 7181191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and antibody responses to equine herpesviruses 1 and 4 following vaccination of horses with modified-live and inactivated viruses.
    Ellis JA; Bogdan JR; Kanara EW; Morley PS; Haines DM
    J Am Vet Med Assoc; 1995 Mar; 206(6):823-32. PubMed ID: 7538990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of inactivated vaccine for Akabane disease.
    Kurogi H; Inaba Y; Takahashi E; Sato K; Goto Y; Satoda K; Omori T; Hatakeyama H
    Natl Inst Anim Health Q (Tokyo); 1978; 18(3-4):97-108. PubMed ID: 740047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral haemorrhagic disease of rabbits: vaccination and immune response.
    Argüello Villares JL
    Rev Sci Tech; 1991 Jun; 10(2):459-80. PubMed ID: 1760586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study of postvaccinal immunity to sheep-pox].
    Fassi-Fehri M; El-Harrak M; Johnson D; Abbadi M; El-Idrissi AH
    Ann Rech Vet; 1984; 15(1):59-64. PubMed ID: 6091523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response of kori bustards (Ardeotis kori) and houbara bustards (Chlamydotis undulata) to live and inactivated Newcastle disease vaccines.
    Bailey TA; Wernery U; Samour JH; Naldo JL
    J Zoo Wildl Med; 1998 Dec; 29(4):441-50. PubMed ID: 10065854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of pigs with formaldehyde inactivated aluminium hydroxide foot-and-mouth disease vaccines, potentiated with diethylaminoethyldextran (DEAE-D).
    de Leeuw PW; Tiessink JW; Frenkel S
    Zentralbl Veterinarmed B; 1979 Mar; 26(2):85-97. PubMed ID: 231355
    [No Abstract]   [Full Text] [Related]  

  • 13. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis.
    Fohlman J; Pauksen K; Morein B; Bjare U; Ilbäck NG; Friman G
    Scand J Infect Dis Suppl; 1993; 88():103-8. PubMed ID: 8390713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serological immune response following vaccination with inactivated parvovirus vaccines in the dog].
    Murisier N; Pfister R; Ohder H; Kihm U
    Schweiz Arch Tierheilkd; 1983 Dec; 125(12):851-60. PubMed ID: 6320363
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses.
    Sharpe S; Fooks A; Lee J; Hayes K; Clegg C; Cranage M
    Virology; 2002 Feb; 293(2):210-6. PubMed ID: 11886240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative testing of the quality of foot-and-mouth disease vaccines prepared with different virus inactivators].
    Dilovski M; Tekerlekov P
    Vet Med Nauki; 1983; 20(5-6):41-5. PubMed ID: 6318423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the immune responses of sheep against foot-and-mouth disease virus types Asia-1 and O PEG-concentrated aluminium hydroxide gel and oil-adjuvanted vaccines.
    Nair SP; Sen AK
    Vaccine; 1993; 11(7):782-6. PubMed ID: 8393608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.